Yeye Guo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yeye Guo

Showing results (31-40 of 36) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 36 results.

Journal of Experimental & Clinical Cancer Research : CR|August 13, 2022

CD147 mediates epidermal malignant transformation through the RSK2/AP-1 pathwayXu Zhang, Yeye Guo, Ta Xiao, et al.

Journal for Immunotherapy of Cancer|May 20, 2021

Dichotomous and stable gamma delta T-cell number and function in healthy individualsLingling Ou, Huaishan Wang, Qin Liu, et al.

The American Journal of Pathology|October 31, 2024

Programmed Death Ligand-1 in Melanoma and Extracellular Vesicles Promotes Local and Regional Immune Suppression through M2-like Macrophage PolarizationLili Huang, Jingbo Yang, Jinjin Zhu, et al.

Ebiomedicine|May 25, 2023

Patient-derived melanoma organoid models facilitate the assessment of immunotherapiesLingling Ou, Shujing Liu, Huaishan Wang, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2025

DR5 CAR-T cells target melanoma and suppress MDSCs with minimal toxicityHuaishan Wang, Shujing Liu, Prithvi Sinha, et al.

Science Advances|January 15, 2025

Engineered extracellular vesicles with DR5 agonistic scFvs simultaneously target tumor and immunosuppressive stromal cellsYeye Guo, Huaishan Wang, Shujing Liu, et al.

Pageof 4

Search research articles

Showing results (31-40 of 36) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 36 results.

Journal of Experimental & Clinical Cancer Research : CR|August 13, 2022

CD147 mediates epidermal malignant transformation through the RSK2/AP-1 pathwayXu Zhang, Yeye Guo, Ta Xiao, et al.

Journal for Immunotherapy of Cancer|May 20, 2021

Dichotomous and stable gamma delta T-cell number and function in healthy individualsLingling Ou, Huaishan Wang, Qin Liu, et al.

The American Journal of Pathology|October 31, 2024

Programmed Death Ligand-1 in Melanoma and Extracellular Vesicles Promotes Local and Regional Immune Suppression through M2-like Macrophage PolarizationLili Huang, Jingbo Yang, Jinjin Zhu, et al.

Ebiomedicine|May 25, 2023

Patient-derived melanoma organoid models facilitate the assessment of immunotherapiesLingling Ou, Shujing Liu, Huaishan Wang, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2025

DR5 CAR-T cells target melanoma and suppress MDSCs with minimal toxicityHuaishan Wang, Shujing Liu, Prithvi Sinha, et al.

Science Advances|January 15, 2025

Engineered extracellular vesicles with DR5 agonistic scFvs simultaneously target tumor and immunosuppressive stromal cellsYeye Guo, Huaishan Wang, Shujing Liu, et al.

Pageof 4